UK Edition
AdvertiseSubmit Company
Pharma JournalEvidence-Based Pharmaceutical Intelligence
RESEARCH & DEVELOPMENT

AdoRx Therapeutics

About AdoRx Therapeutics

The UK-based drug development startup AdoRx Therapeutics is funded by Epidarex Capital and Sixth Element Capital. AdoRx Therapeutics is working to develop novel cancer treatments that target the adenosine pathway. Adenosine is a key component of the tumour microenvironment that helps cancer avoid the immune system.

Similar Companies

More in Research & Development

AdvertisementTeksyte LTD

List Your Company

Showcase your company to thousands of pharma professionals.

Submit Listing

Advertise With Us

Reach decision-makers in the pharmaceutical industry.

Learn More

We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy